Rigel Pharmaceuticals

RIGL

NASDAQHealth Care

Income Statement

Total Revenue$179.28M

Gross Profit$160.63M

Operating Income$24.19M

EBITDA$28.51M

EBIT$26.28M

Pre-tax Income$121.97M

Net Income$17.49M

Cash Equivalent$42.52M

Total Debt$60.26M

Book Value$-18.23M

Book Value Per Share-1.04

Return on Equity (ROE)+531.78%

Return on Assets (ROA)+10.66%

Return on Invested Capital (ROI)+27.77%

Net Profit Margin+9.75%

Current Ratio2.13

Quick Ratio1.88

Long-Term Debt / Equity15.94